DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 1.65% to $1.19 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.30% to 26,206.89 and the Dow Jones Industrial Average rising 0.27% to 52,487.41.
Inovio Pharmaceuticals Inc. closed 60.05% short of its 52-week high of $2.98, which the company reached on September 9th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 1.63% to $259.10, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.83% to $24.25.
Trading volume (1.2 M) remained 1.4 million below its 50-day average volume of 2.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 9, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 09, 2026 17:23 ET (21:23 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments